Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Evaluating biological activity of compounds by transcription factor activity profiling.

Medvedev A, Moeser M, Medvedeva L, Martsen E, Granick A, Raines L, Zeng M, Makarov S Jr, Houck KA, Makarov SS.

Sci Adv. 2018 Sep 26;4(9):eaar4666. doi: 10.1126/sciadv.aar4666. eCollection 2018 Sep.

2.

Sequence motifs associated with hepatotoxicity of locked nucleic acid--modified antisense oligonucleotides.

Burdick AD, Sciabola S, Mantena SR, Hollingshead BD, Stanton R, Warneke JA, Zeng M, Martsen E, Medvedev A, Makarov SS, Reed LA, Davis JW 2nd, Whiteley LO.

Nucleic Acids Res. 2014 Apr;42(8):4882-91. doi: 10.1093/nar/gku142. Epub 2014 Feb 18.

3.

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.

Burdelya LG, Brackett CM, Kojouharov B, Gitlin II, Leonova KI, Gleiberman AS, Aygun-Sunar S, Veith J, Johnson C, Haderski GJ, Stanhope-Baker P, Allamaneni S, Skitzki J, Zeng M, Martsen E, Medvedev A, Scheblyakov D, Artemicheva NM, Logunov DY, Gintsburg AL, Naroditsky BS, Makarov SS, Gudkov AV.

Proc Natl Acad Sci U S A. 2013 May 14;110(20):E1857-66. doi: 10.1073/pnas.1222805110. Epub 2013 Apr 29.

4.

[Mathematical modeling of group of neurons and astrocytes in ischemic stroke].

Makarov SS, Dzhebrailova IuN, Gracheva ME, Grachev EA, Kochetov AG, Gubskiń≠ LV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(8 Pt 2):59-62. Russian.

PMID:
23390657
5.

Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program.

Martin MT, Dix DJ, Judson RS, Kavlock RJ, Reif DM, Richard AM, Rotroff DM, Romanov S, Medvedev A, Poltoratskaya N, Gambarian M, Moeser M, Makarov SS, Houck KA.

Chem Res Toxicol. 2010 Mar 15;23(3):578-90. doi: 10.1021/tx900325g.

PMID:
20143881
6.

Signaling pathways mediating beta3-adrenergic receptor-induced production of interleukin-6 in adipocytes.

Tchivileva IE, Tan KS, Gambarian M, Nackley AG, Medvedev AV, Romanov S, Flood PM, Maixner W, Makarov SS, Diatchenko L.

Mol Immunol. 2009 Jul;46(11-12):2256-66. doi: 10.1016/j.molimm.2009.04.008. Epub 2009 May 23.

7.

Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.

Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L.

Science. 2006 Dec 22;314(5807):1930-3.

8.

An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes.

Li X, Makarov SS.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17432-7. Epub 2006 Nov 6.

9.

Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes.

Diatchenko L, Romanov S, Malinina I, Clarke J, Tchivilev I, Li X, Makarov SS.

J Leukoc Biol. 2005 Dec;78(6):1366-77. Epub 2005 Oct 4.

PMID:
16204640
10.

Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS, Maixner W.

Hum Mol Genet. 2005 Jan 1;14(1):135-43. Epub 2004 Nov 10.

PMID:
15537663
11.

CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls.

Li X, Bradford BU, Dalldorf F, Goyert SM, Stimpson SA, Thurman RG, Makarov SS.

Arthritis Res Ther. 2004;6(3):R273-81. Epub 2004 Apr 27.

12.

Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints.

Miagkov AV, Varley AW, Munford RS, Makarov SS.

J Clin Invest. 2002 May;109(9):1223-9.

13.
14.

NF-kappaB as a therapeutic target in chronic inflammation: recent advances.

Makarov SS.

Mol Med Today. 2000 Nov;6(11):441-8. Review.

PMID:
11074370
15.

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

Romashkova JA, Makarov SS.

Nature. 1999 Sep 2;401(6748):86-90.

PMID:
10485711
16.

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.

Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13859-64.

17.
18.

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS Jr, Haskill JS, Schwab JH.

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):402-6.

19.

The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta.

Watson JM, Lofquist AK, Rinehart CA, Olsen JC, Makarov SS, Kaufman DG, Haskill JS.

J Immunol. 1995 Nov 1;155(9):4467-75.

PMID:
7594609
20.

Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats.

Makarov SS, Olsen JC, Johnston WN, Schwab JH, Anderle SK, Brown RR, Haskill JS.

Gene Ther. 1995 Aug;2(6):424-8.

PMID:
7584118
21.

Hyperinducible human metallothionein promoter with a low level basal activity.

Makarov SS, Jonat C, Haskill S.

Nucleic Acids Res. 1994 Apr 25;22(8):1504-5. No abstract available.

Supplemental Content

Loading ...
Support Center